EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 23 (Octobre 2007) Hors série n° 3 Med Sci (Paris), 23 (2007) 19-21 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 23, Octobre 2007
Le cancer du sujet âgé : le dilemme du vieillissement
Page(s) 19 - 21
Section M/S revues
DOI https://doi.org/10.1051/medsci/2007233s19
Publié en ligne 15 octobre 2007
  1. Dimri GP, Campisi J. Molecular and cell biology of replicative senescence. Cold Spring Harb Symp Quant Biol 1994; 59 : 67–73. [Google Scholar]
  2. Dimri GP, Testori A, Acosta M, Campisi J. Replicative senescence, aging and growth-regulatory transcription factors. Biol Signals 1996; 5 : 154–62. [Google Scholar]
  3. Guarente L. Aging. What makes us tick ? Science 1997; 275 : 943–4. [Google Scholar]
  4. Guarente L. Chromatin and ageing in yeast and in mammals. Ciba Found Symp 1997; 211 : 104–11. [Google Scholar]
  5. McKeller RN, Fowler JL, Cunningham JJ, et al. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc Natl Acad Sci USA 2002; 99 : 3848–53. [Google Scholar]
  6. Groth A, Weber JD, Willumsen BM, et al. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J Biol Chem 2000; 275 : 27473–80. [Google Scholar]
  7. Weber GF, Ashkar S. Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers. Brain Res Bull 2000; 53 : 421–4. [Google Scholar]
  8. Weber GF, Ashkar S. Stress response genes : the genes that make cancer metastasize. J Mol Med 2000; 78 : 404–8. [Google Scholar]
  9. Burri N, Shaw P, Bouzourene H, et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001; 81 : 217–29. [Google Scholar]
  10. Kastan MB. Wild-type p53 : tumors can’t stand it. Cell 2007; 128 : 837–40. [Google Scholar]
  11. Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445 : 656–60. [Google Scholar]
  12. Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 1997; 15 : 203–11. [Google Scholar]
  13. Zindy F, Soares H, Herzog KH, et al. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ 1997; 8 : 1139–50. [Google Scholar]
  14. Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114 : 1299–307. [Google Scholar]
  15. Melk A, Schmidt BM, Takeuchi O, et al. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 2004; 65 : 510–20. [Google Scholar]
  16. Campisi J. Aging and cancer : the double-edged sword of replicative senescence. J Am Geriatr Soc 1997; 45 : 482–8. [Google Scholar]
  17. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21 : 525–30. [Google Scholar]
  18. Dietrich N, Bracken AP, Trinh E, et al. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J 2007; 26 : 1637–48. [Google Scholar]
  19. Gonzalez S, Klatt P, Delgado S, et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006; 440 : 702–6. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.